ResearchMoz

Nutraceuticals Market in India 2012

Publisher Name » Netscribes (India) Pvt. Ltd.
Published Date » 2012-03-06
No. Of Pages » 83

The healthcare industry in India is showing great progress. There has been considerable increase in spending on healthcare backed by the growing purchasing power of individuals. Moreover, with a lot of importance being given to preventive medication, the nutraceuticals market in India is set to flourish. It is one of the booming markets in India. Predominantly vitamins and minerals derived from oral pills were used for curing certain diseases and ailments. People today are becoming more prone to consume immunity enhancing food supplements and wellness related products. This is promoting the growth of the industry with players diversifying into production of various new varieties of products. Further assistance from the government and increasing demand from consumers will fuel growth in this market.

The report begins with an introduction to the Indian nutraceuticals market and its classification on the basis of the ingredients and benefits incurred from them. This is followed by the market overview section which provides the market size and growth as well as the market share of the various segments in the market, namely, functional foods, dietary supplements and functional beverages. A detailed description of each segment in the market along with the dominant products in the particular category has also been provided. Focusing on one the major sub-segments, an overview of the probiotic market in India has been included. This segment has been highlighted owing to the fact that it is one of the most promising categories under the nutraceutical market and has huge growth potential in the near future with growing interests of players. The genesis of probiotics has been highlighted showing the types dominant in India and the key therapeutic benefits derived from them. This section also contains information regarding the market size and growth of probiotics in functional foods in India as well as the key segments and the active players in this space.

This is followed by an analysis of the drivers leading to growth in the market. This includes increasing shift towards preventive therapies, increasing disposable income, increase in healthcare spending, increasing shift towards self-medication, changing demographics, growth in pharmacy and wellness related retail chains and favorable pricing environment. The key challenges to the market include lack of standardization, marketing and distribution challenges, high pricing and lack of awareness. Several trends have also been identified in the market and this has been provided in the next section. The key trends include fortified foods, ayurvedic nutraceuticals, foreign tie-ups, players educating consumers, encapsulation, and cosmeceuticals and nanoceuticals. A section on government regulations in the industry has also been included. It discusses the Food Safety and Standards Act 2006 that regulates the industry.

The competition section provides an overview of the competitive landscape in the industry and includes a detailed profile of the major players in the market. The Porter’s Five Forces analysis for the cath lab market is provided in this section. A summary of the major public players operating in the market has also been provided in the form of a bubble chart. A bubble chart has also been provided for the major private players. It also includes the list of products and services, key people, financial snapshot, key ratios and key recent developments for the major players.

The various financial transactions as well as the key recent development that have taken place in the market have been also been provided in the subsequent sections. A section providing strategic recommendations has been added at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing their profitability.
Table of Contents

Page 1: Executive Summary
Introduction
Page 2: Definition of Nutraceuticals and their Classifications
Market Overview
Page 3: Nutraceuticals Overview, Market Size and Growth (Value-Wise; 2010 2015e), Market Segmentation (2011)
Page 4: Dietary Supplements Overview and Key Products
Page 5: Functional Foods Overview and Key Products
Page 6: Functional Beverages Overview and Key Products
Probiotic Market
Page 7: Genesis of Probiotics
Page 8: Therapeutic Benefits of Probiotics
Page 9: Probiotics in Functional Foods Overview, Market Size and Growth (Value-Wise; 2010 2015e), Market Segmentation (2011)
Page 10: Major Pharmaceutical Companies Active in the Probiotics Market
Drivers & Challenges
Page 11: Summary
Page 12-17: Drivers
Page 18-20: Challenges
Trends
Page 21: Summary
Page 22-27: Key Trends
Government Regulations
Page 28: Genesis of Food Safety and Standards Act, 2006
Page 29: Food Safety and Standards Act, 2006 Objectives, Key Features and Implications
Competition
Page 30: Market Competition Porters Five Forces Analysis
Page 31: Major Public Companies Summary
Page 32-58: Major Public Players
Dabur India Ltd.
Dr. Reddy's Laboratories Ltd.
Lupin Ltd.
Piramal Healthcare Ltd.
Ranbaxy Laboratories Ltd.
Wockhardt Ltd.
Abbott India Ltd.
GlaxoSmithKline Consumer Healthcare Ltd.
Pfizer Ltd.
Page 59: Major Private Companies Summary
Page 60-79: Major Private Companies
Avesthagen Ltd.
Guardian Lifecare Pvt. Ltd.
Reliance Wellness Ltd.
The Himalaya Drug Company
USV Ltd.
Amway India Enterprises Pvt. Ltd.
Herbalife International India Pvt. Ltd.
Financial Transactions
Page 80: Financial Transactions in the Last 5 Years
Key Developments
Page 81: Recent Developments
Strategic Recommendations
Page 82: Key recommendations
Appendix
Page 83: Appendix


List of Charts & Figures
Market Overview
1. Nutraceuticals Market Size & Growth (Value-Wise, 2010 2015e)
2. Nutraceuticals Market Segmentation (2011)
3. Vitamins and Minerals Market Size & Growth (Value-Wise, 2010 2015e)
Probiotic Market
4. Probiotics in Functional Foods Market Size & Growth (Value-Wise, 2010 2015e)
5. Probiotics in Functional Foods Market Segmentation (2011)
Drivers and Challenges
6. Chronic Diseases in India
7. Per Household Annual Income
8. Aggregate Annual Disposable Income
9. Healthcare Spending
10. Composition of Healthcare Spending
11. Population Above 60 Years in India
12. Pharma Retail Growth
Competition
13. Major Public Companies Summary (Bubble Chart)
14. Major Private Companies Summary (Bubble Chart)
15. Financial Snapshot (All companies except The Himalaya Drug Company)
16. Key Business Segments (only Public Companies)
17. Key Geographic Segments (only Public Companies)


List of Tables
Market Overview
1. Dietary Supplements Key Products and Examples
2. Functional Foods Key Products and Examples
3. Functional Beverages Key Products and Examples
Probiotic Market
4. Therapeutic Benefits of Probiotics
5. Major Pharmaceutical Companies Active in the Probiotics Market
Trends
6. Foreign Tie-Ups
7. Examples of Players Educating Consumers
Competition
8. Company profiles (All companies)
a. Company information
b. Products and services
c. Key people
d. Key Financial Performance Indicators
e. Key Ratios
f. Key Recent Developments
Appendix
9. Ratio Calculations

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Blood-Brain Barrier Technologies Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Blood brain barriers are endothelial cells covering the capillaries of the brain. Some of the functions of these blood-brain barriers are: Preventing pathogens (bacteria and viruses) and immune cells from entering the brain Excluding and metabolizing neurotoxic compounds (drugs, antibodies and plasma proteins) and neurotransmitters from brain and blood Safeguarding neurons’ ion balances Rising global prevalence of Parkinson’s disease, cardiovascular diseases and rapidly aging world’s population are some of the drivers for the blood-brain...
Angina Pectoris Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Angina pectoris market is expected to grow at the CAGR of 3.5% and reach the value of $12,707.4 million by the year 2018. This growth is primarily driven by the increase in number of patients undergoing treatment for angina pectoris and likely approval of new therapies like varespladib and Generx that are in late stage of clinical development. If approved, these products are expected to contribute in the growth of angina pectoris industry as they will be marketed at premium price by their inventor companies. Innovative mechanism of action of these products will lead to...
Bio-Based Levulinic Acid Market - Global Industry Analysis, Potential Applications, Downstream Derivatives Market Size, Share, Trends, Growth And Forecast 2009 - 2019
By - Transparency Market Research
New molecules developed by Segetis, in Minnesota based on esters of levulinic acid made from using bio based hydroxyl compounds and corn cobs are known as levulinic ketals. These can be used to produce a series of products such as plasticizers, polyols for polyurethane foams and solvents. Segetis are constructing a new toll manufacturing plant for their new ketals chemistry in the Midwest and the construction of which was expected to be completed by the end of 2011. Products entering the market would start with solvents. While polyols is expected to be the last to enter in...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...